PRKACA anticorps
-
- Antigène Voir toutes PRKACA Anticorps
- PRKACA (Protein Kinase A, alpha (PRKACA))
-
Reactivité
- Humain
-
Hôte
- Chèvre
-
Clonalité
- Polyclonal
-
Conjugué
- Cet anticorp PRKACA est non-conjugé
-
Application
- Western Blotting (WB), ELISA
- Purification
- Antigen affinity
- Immunogène
- Amino acids ESPAQNTAHLDQ were used as the immunogen for this PRKACA antibody. This sequence is common to isoforms 1-3.
- Isotype
- Ig Fraction
- Top Product
- Discover our top product PRKACA Anticorps primaire
-
-
- Indications d'application
-
Optimal dilution of the PRKACA antibody should be determined by the researcher.
1. Isoforms 1 (351 AA), 2 (343 AA) and 3 (427 AA) may be detected by this Ab.\. Western blot: 1-3 μg/mL,ELISA (peptide) LOD: 1:8000
- Restrictions
- For Research Use only
-
- Buffer
- 0.5 mg/mL in 1X TBS, pH 7.3, with 0.5 % BSA (US sourced) and 0.02 % sodium azide
- Agent conservateur
- Sodium azide
- Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Stock
- -20 °C
- Stockage commentaire
- Aliquot and store the PRKACA antibody at -20°C.
-
- Antigène
- PRKACA (Protein Kinase A, alpha (PRKACA))
- Autre désignation
- PRKACA (PRKACA Produits)
- Synonymes
- anticorps PKACA, anticorps Calpha, anticorps Cs-PKA, anticorps PKCA1, anticorps PKA, anticorps PKCD, anticorps Pkaca, anticorps zgc:158799, anticorps protein kinase cAMP-activated catalytic subunit alpha, anticorps protein kinase, cAMP dependent, catalytic, alpha, anticorps cAMP-dependent protein kinase catalytic subunit, anticorps protein kinase, cAMP-dependent, catalytic, alpha, genome duplicate a, anticorps PRKACA, anticorps Prkaca, anticorps kin-1, anticorps prkacaa
- Sujet
- Additional name(s) for this target protein: PKACA, Protein kinase, cAMP-dependent, catalytic, alpha
- ID gène
- 5566
- Pathways
- Signalisation NF-kappaB, Signalisation Hedgehog, EGFR Signaling Pathway, Neurotrophin Signaling Pathway, Thyroid Hormone Synthesis, Carbohydrate Homeostasis, Myometrial Relaxation and Contraction, M Phase, G-protein mediated Events, Signaling Events mediated by VEGFR1 and VEGFR2, Interaction of EGFR with phospholipase C-gamma, Thromboxane A2 Receptor Signaling, VEGFR1 Specific Signals, Lipid Metabolism, SARS-CoV-2 Protein Interactome, Phosphorylation & l'infection par le SRAS-CoV-2
-